Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.74
+0.34 (3.62%)
At close: Apr 6, 2026, 4:00 PM EDT
9.78
+0.04 (0.41%)
After-hours: Apr 6, 2026, 7:55 PM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $571.85 million as of April 6, 2026. Its market cap has increased by 32.93% in one year.
Market Cap
571.85M
Enterprise Value
445.22M
1-Year Change
32.93%
Ranking
Category
Stock Price
$9.74
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $571.85M, an increase of 314.99%. That is a compound annual growth rate of 13.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 551.90M | 9.42% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 604.63M |
| Ocugen | 603.15M |
| Prime Medicine | 602.07M |
| MiMedx Group | 580.90M |
| Zura Bio | 571.66M |
| Tectonic Therapeutic | 569.31M |
| CorMedix | 560.07M |
| ProKidney | 558.54M |